A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
Status:
Recruiting
Trial end date:
2027-08-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effectiveness of nivolumab with
docetaxel in men with advanced castration resistant prostate cancer who have progressed after
second-generation hormonal manipulation.